15.53k followers • 13 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
|Watchlist||Change today||1-month return||1-year return||Total return|
|The Fight Against COVID19||-4.44%||-||-||-|
|Symbol||Company name||Last price||Change||% change||Market time||Volume||Avg vol (3-month)||Market cap|
|JNJ||Johnson & Johnson||144.44||+0.23||+0.16%||4:00 pm GMT-4||8.66M||6.19M||380.28B|
|PFE||Pfizer Inc.||36||-0.25||-0.69%||4:02 pm GMT-4||21.67M||27.69M||200.05B|
|ABBV||AbbVie Inc.||87.14||-1.46||-1.65%||4:02 pm GMT-4||6.21M||7.01M||153.79B|
|SNY||Sanofi||50.61||+0.75||+1.50%||4:00 pm GMT-4||1.43M||983.15k||128.06B|
|GSK||GlaxoSmithKline plc||37.79||-0.21||-0.55%||4:00 pm GMT-4||3.33M||2.86M||94.63B|
|GILD||Gilead Sciences, Inc.||63.09||-0.31||-0.49%||4:00 pm GMT-4||8.52M||8.71M||79.10B|
|REGN||Regeneron Pharmaceuticals, Inc.||565.19||-6.32||-1.11%||4:00 pm GMT-4||535.66k||756.26k||60.13B|
|TAK||Takeda Pharmaceutical Company Limited||18.6||+0.01||+0.05%||4:00 pm GMT-4||1.18M||998.90k||60.09B|
|MRNA||Moderna, Inc.||67.16||-1.56||-2.27%||4:00 pm GMT-4||6.92M||19.72M||26.50B|
|BNTX||BioNTech SE||63.83||-3.22||-4.80%||4:00 pm GMT-4||1.68M||3.61M||15.20B|
|NVAX||Novavax, Inc.||101.57||-10.06||-9.01%||4:00 pm GMT-4||3.15M||7.71M||6.22B|
|VIR||Vir Biotechnology, Inc.||33.43||+0.54||+1.64%||4:00 pm GMT-4||671.16k||1.38M||4.25B|
|INO||Inovio Pharmaceuticals, Inc.||15.97||-1.01||-5.95%||4:00 pm GMT-4||21.02M||32.80M||2.68B|
Johnson & Johnson announced that its coronavirus vaccine candidate had entered the pivotal human trial phase that will enroll up to 60,000 participants worldwide.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the pricing of senior unsecured notes in an aggregate principal amount of $7.25 billion, in an underwritten, registered public offering, consisting of seven tranches:
Gilead Sciences Inc has agreed to pay $97 million to resolve U.S. government claims it used a purportedly independent charity to pay illegal kickbacks to cover Medicare patients' out-of-pocket costs for its pulmonary arterial hypertension drug Letairis. The U.S. Department of Justice said on Wednesday the settlement resolves allegations that Gilead improperly used the Caring Voice Coalition as a conduit to cover thousands of patients' co-payment obligations. "Gilead used data from CVC that it knew it should not have, and effectively set up a proprietary fund within CVC to cover the co-pays of just its own drug," U.S. Attorney Andrew Lelling in Boston said in a statement.